Biotech—it's complicated. A successful product launch requires grit, determination, and clear direction. But let’s be real, the path to launch isn’t a straight one. There are curves, hard turns, and dead ends. Here’s the good news, you don’t have to navigate the complexities alone. Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.
…
continue reading
Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.
…
continue reading
BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today's most innovative companies. Listen in as Wyant Simboli Principal and branding veteran John Simboli poses the questions "What drives you? How do you create change? Why should people care?" to biopharma leaders and hear insights on this rapidly developing field.
…
continue reading
A podcast to share the tools, tips, tricks and routines of the best biotech executives in the industry in order to help develop the next generation of biotech leaders and expedite the launch of new therapies and transform the lives of patients' all over the world.
…
continue reading
UMBC Mic'd Up Podcast welcomes faculty, students, alumni, and industry thought leaders to share their insights and UMBC experiences.
…
continue reading
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is p ...
…
continue reading
PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership ...
…
continue reading
Helping brilliant woman leaders in biotech and pharma gain influence. Short snackable advice in under 2 minutes.
…
continue reading
Welcome to the Chats with Leaders podcast, this is a podcast for ambitious leaders who want to find the sweet spot between building a career they are proud of, whilst prioritising time for life. Yes, you can do both! Let's face it, modern leadership is a rollercoaster regardless of experience level. At the heart of this podcast is the desire to share hot tips, stories and insights to help you confidently navigate the challenges of work and life. Jenn has supported 1000's of people across the ...
…
continue reading
Dr Phil Richardson explores how to solve complex problems in strategy, innovation and change management using business models created from biological systems. Based on 3.8 billion years of evolution biological systems can provide a unique, if not counterintuitive way of thinking differently. The approach has been successfully used in product and service development, creating new ways of working, improving collaboration and delivering disruptive change.
…
continue reading
Have you ever thought about who the people are behind life-saving breakthroughs? How did they get started in their careers? Why did they choose the Life Sciences? What effect do they hope to cause? These are the questions we explore on The Life Science Effect. Gain insights straight from thought leaders, entrepreneurial game-changers, and business executives leading the Life Sciences. Host Steve Vinson explores what it really takes to be effective in this industry as a leader and innovator w ...
…
continue reading
Leadership is a function of communication --- Great Leadership is a function of great communication. Join Leadership Communication Expert, Author, and Coach John Bates as he draws out the best lessons, insights, and stories of the top leaders he invites to his show; NASA Astronauts, Bestselling Authors, Global Leaders, TED / TEDx speakers, and Entrepreneurs. If you'd like immediately actionable insights, to learn the important lessons from the failures of those who are now spectacularly succ ...
…
continue reading
R
Raising Consciousness with Luke Burrows

1
Raising Consciousness with Luke Burrows
Raising Consciousness with Luke Burrows
Welcome to Raising Consciousness. Where Raising Human Consciousness happens. On the show, we cover topics and have conversations On the show, we cover topics and have conversations across the areas of personal growth, health, well-being, spirituality, sports, and leadership & business to raise human consciousness on the planet and inspire people to live full out.
…
continue reading
P
Patient Empowerment Program: A Rare Disease Podcast

1
Patient Empowerment Program: A Rare Disease Podcast
n-Lorem Foundation
Join the nano-rare disease community! Interviews features leading physicians, scientists, biotech experts, and patient advocates. Lessons teach core concepts about drugs. Our host Dr. Crooke has led the creation of antisense technology and his foundation, n-Lorem, is using this powerful technology to discover, develop, and provide personalized experimental antisense oligonucleotide medicines to nano-rare patients for free, for life. n-Lorem is a non-profit organization established to apply t ...
…
continue reading
Leading Minds podcast by Life Sciences Voice, hosted by Jasmeet Sawhney, delves deep inside the minds of the top life sciences executives, including pharmaceuticals, biotech, medical devices, consumer health, animal health, and leaders from related industries. In every episode, we meet a leader who has made a lasting impact in the life sciences industry and continues to drive the industry forward. We go beyond the name and the title to unravel their personality, their beliefs, their mission, ...
…
continue reading
T
TKG's Healthcare Insights - Exploring Healthcare's Critical Issues


1
TKG's Healthcare Insights - Exploring Healthcare's Critical Issues
The Kinetix Group
Exploring the current events, critical issues, challenges, and trends in healthcare, with a focus on achieving the Quadruple Aim of enhancing patient experience, improving population health, reducing costs, and improving the work life of health care providers and staff. Featuring interviews with leading experts on healthcare operations, leadership, clinical protocols, and policies, so that we can gain valuable Healthcare Insights.
…
continue reading
T
The B2B BRAND180 Podcast with Linda Fanaras


1
The B2B BRAND180 Podcast with Linda Fanaras
Linda Fanaras
Tune in to the B2B BRAND180 Podcast with Linda Fanaras, CEO/Strategist! Linda Fanaras is the founder of Millennium Agency, a B2B brand development and marketing strategy firm, that specializes in helping companies build a powerful brand, identify unique messaging that sets them apart in the market, and uncovers the white space in the market to lock in an effective marketing strategy. A brand expert and marketing strategist, she interviews top industry thought leaders and through this, you wi ...
…
continue reading
So, you want to change the world? With thousands of new startups hitting the scene each year, looking to drive innovation and economic growth across the globe - you are certainly not alone: although, it can feel that way a lot of the time. But what if it didn’t have to? I’m Ashlie Collins and I have been where you are - 3 times so far - and I have experienced the ups and downs of building, scaling and exiting and have committed myself to healing the way startup life works - from the top down ...
…
continue reading
Kim Brown Sims is a board-certified senior executive, global healthcare & biotech consultant and health worker with over 35 years of experience across nonprofit, hospital and healthcare industries. Kim expresses the value of our clinical providers, nurses, doctors, social workers, mental health providers and discusses issues important to those on the front line, issues that the pandemic has brought to light, issues that have been in play for over 30 years. The Pricked podcast talks about the ...
…
continue reading
Experienced change practioner, Petro du Pisani, explores 'change that works' and the people who make it happen.
…
continue reading
Mix Talent is a one-stop life science recruitment & consulting firm helping businesses grow their organizations with full attention to their culture - the most powerful force for talent their is. Mix Talent's podcast - The Mix Tape - brings together voices from the industry including life science leaders, clinicians, patients, HR experts, and other entrepreneurs to feature informative and entertaining conversations between Mix Talent team members and life science leaders. Get in the Mix: htt ...
…
continue reading
We are covering topics on tissue 3D bioprinting, clinical trials in silica, quantum computing in product development, blockchain-powered patient management portals, nanotechnologies, and digital therapeutics. We are also covering topics on leadership in the new pharma paradigm post-COVID-19 and what it will mean to function in the new virtual world we find ourselves in. We will be asking how pharma business models will need to change and what new partnerships will need to develop as a result ...
…
continue reading
What are the signs of burnout? How to cope with burnout? How to recover from burnout? How to avoid burnout? These questions and more, are answered in The Burnout Show with host Jess Jones; a weekly conversation with special guests, who generously share their burnout stories including how they pulled themselves out of the slump. Jess also chats with health and wellness experts on how to best navigate burnout when you’re in the thick of it, as well as how to avoid it returning. Tune in for an ...
…
continue reading
A “Captain of Industry" was a term originally used in the United Kingdom during the Industrial Revolution describing a business leader whose means of amassing a personal fortune contributes positively to the country in some way. This may have been through increased productivity, expansion of markets, providing more jobs, or acts of philanthropy. Lead Host: George Jarkesy, hedge fund manager, founder of several successful companies invites you to listen in as he talk to todays' and tomorrows' ...
…
continue reading
T
The Future of Healthcare: Live With Intent


1
The Future of Healthcare: Live With Intent
Thomas Reichart, Justin Tomlinson
For the past two decades, Thomas Reichart and Justin Tomlinson, authors of Live With Intent, have been consulting leaders in the global healthcare industry. The hosts continue to inspire and advise thought leaders and experts to think beyond their roles, functions, and companies to actively shape the future of patient-driven medicine. Subscribe and become part of creating the future of healthcare.
…
continue reading
B
Business Of Biotech


1
Resilient Biopharma Leadership With Ambrx's Dan O'Connor
42:19
42:19
Play later
Play later
Lists
Like
Liked
42:19
Since Dan O'Connor stepped in as CEO at Ambrx late last year, the company's stock has rallied on the revival of a previously-shelved anti-HER2 ADC. It also raised $78 million and completed its ATM (at-the-market) offering. O'Connor is no stranger to overcoming adversity. A former marine captain, he was among the first deployed to the Persian Gulf t…
…
continue reading
B
Biotech 2050 Podcast


1
BIO Special: Advancing kidney disease care, Eric Dobmeier, President & CEO, Chinook Tx
40:37
40:37
Play later
Play later
Lists
Like
Liked
40:37
Synopsis: Eric Dobmeier is the President and CEO of Chinook Therapeutics, a clinical-stage biopharmaceutical company discovering, developing and commercializing precision medicines for rare, severe chronic kidney diseases. Eric discusses how his early years as a lawyer working in-house as general counsel for Seattle Genetics (now Seagen), ultimatel…
…
continue reading
B
Biotech 2050 Podcast


1
BIO Special: Advancing heart disease treatment, Faraz Ali, CEO, Tenaya Therapeutics
38:03
38:03
Play later
Play later
Lists
Like
Liked
38:03
Synopsis: Faraz Ali is the CEO of Tenaya Therapeutics, a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease. Faraz discusses his non-traditional background as an electrical engineer before he found his passion for applying science an…
…
continue reading
T
The Emerging Biotech Leader


1
Pioneering In The Emerging Field Of Digital Therapeutics - Scott Xiao : 17
32:39
32:39
Play later
Play later
Lists
Like
Liked
32:39
“I won't say that we had this all planned out because when I started, it was just a crazy idea that we were excited about, but it ended up working out really well where we're trying to create a new class of medicine with digital therapeutics or with prescription digital therapeutics.” Scott Xiao, Co-Founder and CEO, Luminopia. What’s possible when …
…
continue reading
B
Business Of Biotech


1
The Innovation Reduction Act with Allan Shaw
37:47
37:47
Play later
Play later
Lists
Like
Liked
37:47
Allan Shaw isn't the only insider who's preemptively critical of the impact the IRA (Inflation Reduction Act) will have on the biopharma industry. Allan's back this week with analysis of what he and others are tongue-in-cheek calling the "innovation reduction act." He posits that the act's removal of certain protections will stifle momentum by disi…
…
continue reading
B
Biotech 2050 Podcast


1
Drugging the undruggable with Gregory Verdine, Co-Founder, President & CEO, Lifemine Tx & FogPharma
46:53
46:53
Play later
Play later
Lists
Like
Liked
46:53
Synopsis: Gregory Verdine, Ph.D., is the Co-Founder, President and CEO of LifeMine Therapeutics and FogPharma. LifeMine Therapeutics is reinventing drug discovery by mining genetically-encoded small molecules (GEMs) from the biosphere. FogPharma is developing a new class of drugs to address the limitations of today’s precision medicines and achieve…
…
continue reading
Let's take a deep breath and fill our lungs with air. Ahh, doesn't that feel good? Our lungs are responsible for taking in oxygen from the air we breathe and distributing it to organs throughout our bodies and then ridding those organs of carbon dioxide. Get ready to dive into a fascinating episode on our lungs and how they protect us against parti…
…
continue reading
B
Biotech 2050 Podcast


1
Pioneering precision therapies for cancer & blood disorders, Kate Haviland, CEO, Blueprint Medicines
27:19
27:19
Play later
Play later
Lists
Like
Liked
27:19
Synopsis: Kate Haviland is the CEO of Blueprint Medicines, a global precision therapy company that creates life-changing medicines for people with cancer and blood disorders. Applying an approach that is both precise and agile, they create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of di…
…
continue reading
B
Business Of Biotech


1
Propagating Peptides With Peptilogics' Jonathan Steckbeck, Ph.D.
51:02
51:02
Play later
Play later
Lists
Like
Liked
51:02
The Business of Biotech took a road trip to Pittsburgh to visit with Peptilogics CEO and founder Dr. Jonathan Steckbeck, whose Ph.D. work was inspired by the loss of his father-in-law to a hospital-borne infection. That work subsequently led to the formation of a company committed to leveraging peptide therapeutics to address PJI (prosthetic joint …
…
continue reading
Naseem Amin, CEO of Orphalan, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Orphalan is working to transform rare disease treatment.By John Simboli
…
continue reading
B
Biotech 2050 Podcast


1
Targeting highly dynamic proteins to develop precision medicines, Asit Parikh, Pres. & CEO, MOMA Tx
30:07
30:07
Play later
Play later
Lists
Like
Liked
30:07
Synopsis: Asit Parikh, M.D., Ph.D., is the President and CEO of MOMA Therapeutics, a biotech company discovering the next generation of precision medicines by targeting highly dynamic proteins that underlie human disease. Asit discusses his experience and learnings being the CEO of a biotech for the first time and his approach to recruiting high qu…
…
continue reading
C
Chats with Leaders


1
Mastering your own destiny with Emilie Neff, Head of People & Organisation @ Novartis - Captain of Hoist the Colors
48:40
48:40
Play later
Play later
Lists
Like
Liked
48:40
Every now and then you connect with someone with such great energy, who you feel like you have known your entire life… Emilie is one of those people, and so it is with such joy that I bring this chat to you. In this insightful episode we dive into topics such as how to be the master of your own destiny, tap into your own inner wisdom to create a me…
…
continue reading
B
Biotech 2050 Podcast


1
RNA-guided programmable therapeutics for fibrosis, Samir Ounzain, CEO & Co-Founder, HAYA Tx
26:36
26:36
Play later
Play later
Lists
Like
Liked
26:36
Synopsis: Samir Ounzain is the CEO and Co-Founder of HAYA Therapeutics, a precision medicines company developing RNA-guided programmable therapeutics targeting the regulatory genome for serious health conditions including fibrosis. Samir discusses the current landscape as it relates to precision medicine and genomic medicine and what his team is ho…
…
continue reading
P
Patient Empowerment Program: A Rare Disease Podcast

1
One Year Anniversary: It Takes a Rare Community
45:43
45:43
Play later
Play later
Lists
Like
Liked
45:43
May marks a year of podcasting for us, and we’re thankful for all those who have participated and the growing number of people who have listened to the podcasts. We are pleased with the overwhelming support for the podcast and the willingness of our partners and patients to share their stories. We launched our Patient Empowerment Program with the p…
…
continue reading
Welcome back to the UMBC Mic'd Up Podcast! In today's episode, we are thrilled to bring insights from two of our esteemed graduate instructors, Dr. Milos Miljkovic and Dr. Wilson Bryan. Both bring a wealth of knowledge and experience to our Biotechnology Graduate Program at UMBC. Dr. Miljkovic and Dr. Bryan will delve into the nitty-gritty of a new…
…
continue reading
T
The Emerging Biotech Leader


1
How To Juggle Priorities As A CMO - Hootan Khatami : 16
22:36
22:36
Play later
Play later
Lists
Like
Liked
22:36
“You may not have the resources as a CMO, especially with smaller biotech companies, but you have to be resourceful.” Ramin Farhood, Senior Vice President, SSI Strategy Every guest on the Emerging Biotech Leader builds on the insights from our previous contributors while also adding their own unique best practices, analogies and experience. In that…
…
continue reading
B
Business Of Biotech


1
Funding A Neurodegeneration Startup With Coya Therapeutics' Howard Berman
49:30
49:30
Play later
Play later
Lists
Like
Liked
49:30
Like many of us, Howard Berman, Ph.D. has personal experience with the tragedy of cognitive decline. Neurodegenerative disorders are on the rise, and when one afflicted his father — a triple board-certified physician — he saw firsthand that they don't discriminate. Berman has dedicated his career to addressing neuro, autoimmune, and metabolic disea…
…
continue reading
P
PharmaTalkRadio


1
CRAACO Director's Note Podcast on What to Expect in Under 6 Minutes
6:00
6:00
Play later
Play later
Lists
Like
Liked
6:00
Director, Valerie Bowling, reviews what to expect at the upcoming Clinical Research as a Care Option (CRAACO) conference taking place on May 22-23 at the Sheraton Imperial Hotel in Raleigh-Durham, NC.By Pharma Talk Radio
…
continue reading
B
Biotech 2050 Podcast


1
Single-course gene editing for cardiovascular disease, Sekar Kathiresan, Co-Founder & CEO, Verve Tx
31:44
31:44
Play later
Play later
Lists
Like
Liked
31:44
Synopsis: Sekar Kathiresan is the Co-Founder, CEO and Board Member of Verve Therapeutics, a clinical-stage biotechnology company developing gene editing medicines to treat patients with cardiovascular disease. Sekar discusses Verve’s work developing single-course, in vivo liver-directed gene editing medicines for patients with and at risk of cardio…
…
continue reading
T
The B2B BRAND180 Podcast with Linda Fanaras


1
Preparing B2B Marketers for the AI-Driven Future of SEO and Content Marketing: Insights from AI Innovator, CTO & SEO Expert Alexander De Ridder
34:55
34:55
Play later
Play later
Lists
Like
Liked
34:55
In this episode of B2B Brand180, Linda interviews Alexander De Ridder, a renowned AI innovator, CTO, SEO expert, and the co-founder of Ink. As a pioneer in Natural Language Optimization models and the creator of a patented AI method that demystifies Google's content preferences, Alexander offers a wealth of knowledge. The conversation dives into th…
…
continue reading
B
Business Of Biotech


1
A More NIIMBL Biotech Workforce With John Balchunas
1:03:07
1:03:07
Play later
Play later
Lists
Like
Liked
1:03:07
What are biopharma's greatest skilled manufacturing labor needs, and what's the industry doing to fill them? John Balchunas is on the front lines in his position as Workforce Director at NIIMBL, the National Institute for Innovation in Manufacturing Biopharmaceuticals, and he says advanced degrees and pedigrees aren't the answer. The breadth and de…
…
continue reading
B
Biotech 2050 Podcast


1
Leading personalized immune medicines, Harlan Robins, CSO & Co-Founder, Adaptive Biotechnologies
23:58
23:58
Play later
Play later
Lists
Like
Liked
23:58
Synopsis: Harlan Robins, Ph.D., is the CSO and Co-Founder of Adaptive Biotechnologies, a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with…
…
continue reading
P
Patient Empowerment Program: A Rare Disease Podcast

1
Coming Together for the Nano-rare Patient
31:53
31:53
Play later
Play later
Lists
Like
Liked
31:53
This episode is proudly sponsored by our partner, Alnylam Pharmaceuticals, the leading RNAi therapeutics company. When Stan Crooke ran Ionis and John Maraganore ran Alnylam, they were partners that turned into rivals — and not always friendly ones — as they persevered to pursue an entirely new therapeutic space; RNA-targeted drug discovery and deve…
…
continue reading
T
The B2B BRAND180 Podcast with Linda Fanaras


1
Marketing and HR Collaboration for B2B Brand Success with Jillian Derby of AIM HR Solutions
18:42
18:42
Play later
Play later
Lists
Like
Liked
18:42
In this episode, Linda Fanaras speaks with Jillian Derby, Senior Marketing Director at AIM HR Solutions, to discuss the often-overlooked synergy between HR and marketing departments in the B2B space. They explore how a unified approach can lead to better employee engagement, improved brand messaging and, ultimately, increased sales. Thanks for list…
…
continue reading
B
Business Of Biotech


1
Building Flagship Pioneering With Avak Kahvejian, Ph.D.
59:45
59:45
Play later
Play later
Lists
Like
Liked
59:45
Flagship Pioneering is fertile ground for a bevy of blossoming biotechs, and one of its most prolific sowers is General Partner Avak Kahvejian, Ph.D. Dr. Kahvejian counts Seres Therapeutics, Rubius Therapeutics, Codiak BioSciences, Cygnal Therapeutics, Ring Therapeutics, Cellarity, Laronde, and Generate Biomedicines among the companies he's played …
…
continue reading
T
The Emerging Biotech Leader


1
Navigating The CMO Role - Chris Morabito : 15
44:32
44:32
Play later
Play later
Lists
Like
Liked
44:32
“The expansions of your expertise and your external network are two key fundamental things that one should be focusing on as you think about developing your career towards a CMO pathway.” Dr. Christopher Morabito, Astria Therapeutics. Welcome to this week’s Emerging Biotech Leader recap. In our previous Episodes, we touched on the topic of careers …
…
continue reading
R
Raising Consciousness with Luke Burrows

1
RC45: Start Before You Are Ready with Vamsi Polimetla
50:04
50:04
Play later
Play later
Lists
Like
Liked
50:04
There is a lot of content, talk, and opinions about what success is and how to reach it that oftentimes it can be overwhelming. If there is one general principle when it comes to success it's that starting before you are ready seems to be the path most trodden. In this episode of Raising Consciousness, Vamsi Polimetla stops by to talk about success…
…
continue reading
B
Biotech 2050 Podcast


1
Advancing RNA medicines in genetic diseases, Paul Bolno, President & CEO, Wave Life Sciences
32:51
32:51
Play later
Play later
Lists
Like
Liked
32:51
Synopsis: Dr. Paul Bolno is the President and CEO of Wave Life Sciences, a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases including Duchenne muscular dystrophy and Alpha-1 antitrypsin deficiency. Paul discusses his early years at GSK and the events that led him to join …
…
continue reading
L
Leading Minds By Life Sciences Voice


1
Chumi Khurana: The role of commercial organization in improving cancer care
32:38
32:38
Play later
Play later
Lists
Like
Liked
32:38
Chumi Khurana is a dynamic leader at Janssen Global Commercial Strategy Organization and Chairperson of the Eastern Pennsylvania and Delaware Chapter of the Leukemia and Lymphoma Society. Today, she shares her career path and philosophy of leadership. Learn fundamental skills for empowering your employees to be their best and develop their leadersh…
…
continue reading
U
UMBC Mic'd Up


1
Discovering Technical Advancements through Data Science
25:37
25:37
Play later
Play later
Lists
Like
Liked
25:37
In this episode of UMBC Mic'd Up podcast, we explore the exciting world of data science and how it can lead to discovering new technologies. Our guest, Daniel Rimdans, M.P.S. '22, Data Science, who was laid off from their job as an environmental scientist during the pandemic, shares how his fascination with data led him to pursue further education.…
…
continue reading
C
Chats with Leaders


1
Resilience as a superpower; turning lemons into lemonade with Ashley Cox, Head of Europe and Senior Principal @ Eversana Consulting
52:09
52:09
Play later
Play later
Lists
Like
Liked
52:09
What can I say, Ashley Cox and I have grownup in the Pharmaceutical industry together. Since we first met over 19 years ago, and I hired her into the industry (I have a knack for identifying top talent!), it has been an absolute joy to see her career evolve and go from strength to strength. Ashley now heads up the European region for Eversana Consu…
…
continue reading
B
Business Of Biotech


1
Therapeutic Molecules From Moss with eleva's Andreas Schaaf and Björn Cochlovius, Ph.D.
1:00:42
1:00:42
Play later
Play later
Lists
Like
Liked
1:00:42
We kick this conversation off with the writer Elizabeth Gilbert's take on moss, which she so eloquenlty dubs a "resurrection engine." Gilbert almost certianly didn't realize the potential of moss to play a resurrectional role in human health, but Eleva Biotech's Andreas Schaaf and Bjorn Cochlovius do. On this episode of the Business of Biotech, we …
…
continue reading
Hartmut Ehrlich, CEO of Abivax, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Abivax is working to develop treatments modulating the body’s natural immune system to treat patients with chronic inflammatory diseases, viral infections and cancer.By John Simboli
…
continue reading
R
Raising Consciousness with Luke Burrows

1
RC44: High-School Drop-Out to Vice President of a Biotech Company with a £1.6 Billion Revenue with Pradeep Sacitharan
45:02
45:02
Play later
Play later
Lists
Like
Liked
45:02
I've come to realise how important hope can be in people changing their lives for the better. And, there is arguably no better hope than seeing people like you, from your background, culture, and/or similar life experiences go on to do the extraordinary. In this episode, we're joined by an inspirational guest who has gone from a teenage gangster an…
…
continue reading
B
Biotech 2050 Podcast


1
Leadership in revolutionizing cancer immunotherapy, Garo Armen, Ph.D., Chairman & CEO, Agenus
27:44
27:44
Play later
Play later
Lists
Like
Liked
27:44
Synopsis: Garo Armen, Ph.D., is the Chairman and CEO of Agenus, an immuno-oncology company with the goal of treating cancers with novel combinations utilizing its unique portfolio of checkpoint antibodies, tumor microenvironment modifiers, vaccines and adjuvants. After receiving his Ph.D. in chemistry, Dr. Armen worked on Wall Street where he speci…
…
continue reading
Amber Freed and Shanna Tolbert join n-Lorem founder and CEO, Stan Crooke, for the first ever Patient Empowerment Program Q&A episode. Amber and Shanna are two nano-rare patient mothers and rare disease advocates who have experience with the n-Lorem pathway to treatment as caregivers. Through their experiences, and by canvasing others in the nano-ra…
…
continue reading
T
The Emerging Biotech Leader


1
Medical Affairs Should Start Long Before Product Launch : 14
30:07
30:07
Play later
Play later
Lists
Like
Liked
30:07
In Medical Affairs, timing is everything. If we had to summarize this next Episode of the Emerging Biotech Leader in one sentence, it would be “a deeper dive on both the impact and importance of Medical Affairs,” inspired by our interview with Rachel Couchenour in Episode 13. But that single sentence alone wouldn’t convey the robust takeaways and m…
…
continue reading
B
Business Of Biotech


1
Gene Tx For Hearing Loss with Sensorion's Nawal Ouzren
54:18
54:18
Play later
Play later
Lists
Like
Liked
54:18
We often talk about biotechs taking "big swings." This week's guest is swinging for the fences with a lineup of gene therapies designed to address multiple forms of hearing loss, which affect multiple millions (if not, billions) of people worldwide. Adding to the challenge she's accepted, Sensorion CEO Nawal Ouzren is architecting an approach that …
…
continue reading
R
Raising Consciousness with Luke Burrows

1
RC43: What is Accessing Consciousness and How Can It Help Neurodiversity with Diva Diaz
47:19
47:19
Play later
Play later
Lists
Like
Liked
47:19
We live in a world that uses labels to distinguish differences so we can understand what is often a complex world with so many unknowns. This can often lead us to not want to stand out for the fear of being labeled as different and sometimes even ostracised by friends, family, peers, and society at large. This is particularly true for certain backg…
…
continue reading
B
Biotech 2050 Podcast


1
Revolutionizing brain health: CNS innovations, AI & more, Craig Thompson, CEO, Cerevance
23:52
23:52
Play later
Play later
Lists
Like
Liked
23:52
Synopsis: Craig Thompson is the CEO of Cerevance, a clinical-stage drug discovery and development company focused on developing novel therapeutics for central nervous system diseases. He discusses the arc of his career, beginning at big pharma at Merck and Pfizer before transitioning to biotech, and his learnings along the way. As CEO, he shares wh…
…
continue reading
T
The B2B BRAND180 Podcast with Linda Fanaras


1
Creating a Remarkable B2B Brand: Insights from Strategy Consultant and Sticky Branding Founder Jeremy Miller
25:29
25:29
Play later
Play later
Lists
Like
Liked
25:29
In this episode of the B2B Brand180 podcast, host Linda Fanaras is joined by Jeremy Miller, founder of Sticky Branding and a leading strategy consultant. Together, they dive into the world of branding and discuss what it takes to create a truly remarkable brand in today's competitive market. Miller shares his insights into how businesses can differ…
…
continue reading
B
Business Of Biotech


1
Functional Ectopic Organs with LyGenesis' Michael Hufford, Ph.D.
51:24
51:24
Play later
Play later
Lists
Like
Liked
51:24
LyGenesis is developing a pipeline of allogeneic cell therapies using the lymph node as an in vivo bioreactor to grow functioning ectopic organs. What sounds like science fiction to some is starting to look like a life changing therapy for millions of liver, kidney, pancreas, and thymus disease sufferers. The science behind it is being developed no…
…
continue reading
T
The Emerging Biotech Leader


1
Making A Mark In Medical Affairs - Rachel Couchenour : 13
39:29
39:29
Play later
Play later
Lists
Like
Liked
39:29
“I've found that it's usually not the ‘what’ or the ‘how’ that will get me where I need to go with a Senior leader. It's the why. They want to understand the why behind it.” Rachel Couchenour, VP, Global Medical Affairs, Travere Therapeutics. Working cross-functionally. Some would call it a skill. Others would say it’s a talent. For our guest on Ep…
…
continue reading
R
Raising Consciousness with Luke Burrows

1
RC42: What Are Your Real Values with Dr. John Demartini
1:06:57
1:06:57
Play later
Play later
Lists
Like
Liked
1:06:57
Many self-development, personal growth, and mindset gurus, leaders and so-called experts share ideas and use imperative language like, ‘you must wake up at 5 am’ or ‘you should exercise in the morning before the family wakes up' or 'you must read 50 pages per day' without understanding that no two individuals are exactly the same and that these wel…
…
continue reading
Welcome to our latest podcast episode, where we sit down with Samantha Novak, a UMBC graduate faculty member, to discuss leading with emergent strategies. In this thought-provoking conversation, Ms. Novak shares her insights on the importance of reflecting on our work in the world and how we choose to show up to it. We delve into the idea that real…
…
continue reading
B
Biotech 2050 Podcast


1
Mental health: psychedelics & beyond, Florian Brand, CEO, & Srinivas Rao, CSO, atai Life Sciences
33:32
33:32
Play later
Play later
Lists
Like
Liked
33:32
Synopsis: We recorded this episode in December 2022 with Florian Brand and Srinivas Rao, the Co-Founders and CEO & CSO, respectively, of atai Life Sciences, a biopharmaceutical company that leverages a decentralized platform approach to incubate and accelerate the development of highly effective mental health treatments that address the unmet needs…
…
continue reading
P
Patient Empowerment Program: A Rare Disease Podcast

1
Bits and Bytes Help Streamline Bench to Bedside
21:41
21:41
Play later
Play later
Lists
Like
Liked
21:41
The creation of a drug consists of a copious and complicated series of projects that are all intertwined. Andy Mehrotra, CEO of Unipr, joins the Patient Empowerment Program to discuss how Unipr’s AI based cloud program, project, and portfolio management platforms allow organizations like n-Lorem to quickly analyze data to inform program management.…
…
continue reading
B
Business Of Biotech


1
Approvals & Mergers: Inside Enzyvant with Bill Symonds, Pharm.D.
56:18
56:18
Play later
Play later
Lists
Like
Liked
56:18
Today's episode of the Business of Biotech covers a lot of ground with Enzyvant CEO Bill Symonds, Pharm.D. Among other things, we discuss the career moves Dr. Symonds has made within the "vant" environment since his involvement in the launch of the original Roivant, the approval of Rethymic, the merger of Altavant and Enzyvant, and the company's in…
…
continue reading
B
BioBoss


1
#58 - Ivo Timmermans: co-founder & CEO, Pleco Therapeutics
41:32
41:32
Play later
Play later
Lists
Like
Liked
41:32
Ivo Timmermans, co-founder and CEO of Pleco Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Pleco is working to develop breakthrough therapies that change the balance in the treatment of cancer.By John Simboli
…
continue reading
R
Raising Consciousness with Luke Burrows

1
RC41: Leadership, Navigating Relationships, and Positivity with Jonathan Darling
1:05:58
1:05:58
Play later
Play later
Lists
Like
Liked
1:05:58
Whether we consciously recognise it or not we are all leaders in our own right because before we can lead others we first learn to lead ourselves. Yet, we mistake leadership for being a particular role, position, or title and while we take on these roles they by themselves don't make us a leader. A leader has very little to do with the titles we as…
…
continue reading